I. Bièche
Laboratoire de Génétique Moléculaire-UPRES JE 2195
Faculté des Sciences Pharmaceutiques et Biologiques
Université René Descartes-Paris V
Paris
France
Name/email consistency: high
- Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays. Bièche, I., Olivi, M., Noguès, C., Vidaud, M., Lidereau, R. Br. J. Cancer (2002)
- Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction. Bièche, I., Franc, B., Vidaud, D., Vidaud, M., Lidereau, R. Thyroid (2001)
- Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene. Bièche, I., Parfait, B., Tozlu, S., Lidereau, R., Vidaud, M. Carcinogenesis (2001)
- ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinoma. Bièche, I., Onody, P., Lerebours, F., Tozlu, S., Hacene, K., Andrieu, C., Vidaud, M., Tubiana-Hulin, M., Spyratos, F., Lidereau, R. Cancer Lett. (2001)
- Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. Bièche, I., Parfait, B., Laurendeau, I., Girault, I., Vidaud, M., Lidereau, R. Oncogene (2001)